Boxer Capital, LLC Vincerx Pharma, Inc. Transaction History

Boxer Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.0 - $0.0 $0 - $0	-450,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$0.0 - $27.0 $0 - $12.2 Million	450,000 New	450,000 $5.85 Million
Q1 2021 May 17, 2021	SELL	$22.6 - $31.0 $6.78 Million - $9.3 Million	-300,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$12.85 - $19.95 $3.86 Million - $5.99 Million	300,000 New	300,000 $6.27 Million

10.7M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $14.4M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.